Lonza Group Ag Total Assets 2012-2023 | LZAGY
Lonza Group Ag total assets from 2012 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Lonza Group Ag total assets for the quarter ending December 31, 2023 were $18.767B, a 12.77% increase year-over-year.
- Lonza Group Ag total assets for 2022 were $18.187B, a 1% increase from 2021.
- Lonza Group Ag total assets for 2021 were $18.008B, a 17.01% increase from 2020.
- Lonza Group Ag total assets for 2020 were $15.39B, a 10.47% increase from 2019.
| Lonza Group Ag Annual Total Assets (Millions of US $) |
|
|---|---|
| 2022 | $18,187 |
| 2021 | $18,008 |
| 2020 | $15,390 |
| 2019 | $13,931 |
| 2017 | $14,015 |
| 2016 | $6,932 |
| 2015 | $6,502 |
| 2014 | $7,048 |
| 2013 | $7,061 |
| 2012 | $7,576 |
| 2011 | $7,949 |
| Lonza Group Ag Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2023-12-31 | $18,767 |
| 2022-12-31 | $18,187 |
| 2022-06-30 | $17,339 |
| 2021-12-31 | $18,008 |
| 2021-06-30 | $16,642 |
| 2020-12-31 | $15,390 |
| 2020-06-30 | $14,473 |
| 2019-12-31 | $13,931 |
| 2019-06-30 | $13,462 |
| 2018-12-31 | $14,228 |
| 2018-06-30 | $14,215 |
| 2017-12-31 | $14,015 |
| 2017-06-30 | $9,740 |
| 2016-12-31 | $6,932 |
| 2016-06-30 | $6,485 |
| 2015-12-31 | $6,502 |
| 2015-06-30 | $6,424 |
| 2014-12-31 | $7,048 |
| 2014-06-30 | $7,427 |
| 2013-12-31 | $7,061 |
| 2013-06-30 | $7,431 |
| 2012-12-31 | $7,576 |
| 2012-06-30 | $7,502 |
| 2011-12-31 | $7,949 |
| 2011-06-30 | $5,065 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $41.070B | $7.478B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
| Stryker (SYK) | United States | $123.816B | 30.70 |
| Medtronic (MDT) | Ireland | $105.535B | 14.94 |
| Boston Scientific (BSX) | United States | $98.780B | 32.84 |
| EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
| ResMed (RMD) | United States | $26.307B | 26.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
| Terumo (TRUMY) | Japan | $24.492B | 34.59 |
| Baxter (BAX) | United States | $20.044B | 14.62 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.641B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
| Demant (WILYY) | Denmark | $9.965B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
| BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
| Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
| Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
| Haemonetics (HAE) | United States | $4.126B | 21.10 |
| GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
| Envista Holdings (NVST) | United States | $3.430B | 13.05 |
| QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
| Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
| Neogen (NEOG) | United States | $2.515B | 24.19 |
| ICU Medical (ICUI) | United States | $2.333B | 17.41 |
| TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
| Owens & Minor (OMI) | United States | $1.899B | 18.23 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
| InMode (INMD) | Israel | $1.462B | 7.57 |
| LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
| AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
| Warby Parker (WRBY) | United States | $1.185B | 0.00 |
| AtriCure (ATRC) | United States | $1.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.977B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
| Evolus (EOLS) | United States | $0.668B | 0.00 |
| Quanterix (QTRX) | United States | $0.605B | 0.00 |
| Jin Medical (ZJYL) | China | $0.600B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
| Valneva SE (VALN) | France | $0.528B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
| PetIQ (PETQ) | United States | $0.479B | 17.89 |
| ZimVie (ZIMV) | United States | $0.420B | 25.72 |
| Biote (BTMD) | United States | $0.413B | 3.93 |
| OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
| Surmodics (SRDX) | United States | $0.377B | 40.75 |
| Zynex (ZYXI) | United States | $0.366B | 42.15 |
| Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Veru (VERU) | United States | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
| Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.091B | 0.00 |
| Brainsway (BWAY) | Israel | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| United Health Products (UEEC) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.30 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |